Dietary Fatty Acid Oxidation is Decreased in Non-Alcoholic Fatty Liver Disease: A Palmitate Breath Test Study.

Background & Aim Hepatic fat excess in non-alcoholic fatty liver disease (NAFLD) reflects an imbalance between fat accumulation and disposal. Conflicting data exist for the role of fatty acid oxidation (FAO), one of the disposal pathways, and have mostly come from the studies delivering fatty acids (FAs) intravenously. Whether FAO of orally provided FAs is affected in NAFLD is unknown. Methods We performed a breath test study to measure FAO in subjects with NAFLD and healthy controls. Subjects ingested [1-C-13] palmitic acid (PA, 10 mg/kg) in a liquid meal and the rate of (CO2)-C-13 appearance in expired air was measured over 6 hours by a BreathID device (Exalenz) to obtain the cumulative percent dose recovered (CPDR), the total amount of ingested C-13 recovered. CPDR was corrected by the results of a [1-C-13] acetate breath test, performed 1-4 weeks later, to calculate the rate of PA beta-oxidation. Results Palmitic acid oxidation was 27% lower in 43 subjects with NAFLD compared to 11 controls (CPDR 9.5 +/- 2.4% vs 13.1 +/- 3.7%, P = .0001) and this persisted after correcting for acetate (29.3 +/- 10.5 vs 36.6 +/- 13.9, P = .03). The decrease in FAO was not because of the delayed transit as the time to peak C-13 detection did not differ between groups (4.9 +/- 1.2 hours vs 4.7 +/- 0.8 hours, P = .7). Rates of PA oxidation were not correlated with obesity, hepatic or adipose insulin resistance, alanine aminotransferase, liver fat content and NAFLD histology. Conclusion Fatty acid oxidation of orally delivered FA is decreased in NAFLD compared to healthy controls, likely reflecting decreased beta-oxidation. The use of a breath test offers non-invasive dynamic assessment of FAO.